Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda

Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda

Background: The injectable hormonal contraceptive depo-medroxyprogesterone acetate (DMPA) has been associated with increased risk of HIV acquisition, but findings are inconsistent. Whether DMPA increases the risk of other sexually transmitted viral infections is unknown. We assessed the association...

Full description

Bibliographic Details
Main Authors: Mary K Grabowski, PhD, Prof. Ronald H Gray, MD, Fred Makumbi, PhD, Joseph Kagaayi, MBChB, Andrew D Redd, PhD, Godfrey Kigozi, MBChB, Steven J Reynolds, MD, Fred Nalugoda, MHS, Tom Lutalo, MS, Prof. Maria J Wawer, MD, Prof. David Serwadda, MD, Prof. Thomas C Quinn, MD, Aaron A R Tobian, MD
Format: Article
Language:English
Published: Elsevier 2015-08-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X15000868

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X15000868

Similar Items